Clinical Trials
Closed
Phase
Accrual
62%
Published
SWOG Clinical Trial Number
S0026
Evaluation of Interferon Alpha-2b and Thalidomide in Patients with Disseminated Malignant Melanoma, Phase II
Research Committee(s)
Melanoma
Activated
11-01-2001
Closed
05-01-2003
Closed
Phase
Accrual
13%
SWOG Clinical Trial Number
S9908
A Double-Blind, Placebo-Controlled Trial to Study the Efficacy and Safety of L-Glutamine (in AES0014 Delivery Vehicle) Upon Radiation Therapy-Induced Oral Mucositis in Head and Neck Cancer Patients, Phase III
Research Committee(s)
Head and Neck Cancer
Activated
11-01-2001
Closed
04-15-2005
Closed
Phase
Accrual
46%
Published
SWOG Clinical Trial Number
S0001
A Phase III Study of Radiation Therapy (RT) and O6-Benzylguanine (O6-BG) Plus BCNU versus RT and BCNU Alone for Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma
Research Committee(s)
Brain Cancer
Activated
09-01-2001
Closed
11-15-2005
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0027
Phase II Trial of Sequential Vinorelbine and Docetaxel in Advanced Non-Small Cell Lung Cancer Patients Age Seventy and Older, or with Performance Status 2
Research Committee(s)
Lung Cancer
Activated
09-01-2001
Closed
07-01-2003
Closed
Phase
Accrual
16%
SWOG Clinical Trial Number
S0020
A PHASE II STUDY OF ANTI-THYMOCYTE GLOBULIN AND CYCLOSPORINE FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS)
Research Committee(s)
Leukemia
Activated
08-15-2001
Closed
05-15-2003
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0112
S0112, A Phase II Study Of Daunomycin And Ara-C, Both Given By Continuous IV Infusion For Previously Untreated Non-M3 Acute Myeloid Leukemia (AML) In Patients Of Age 56 Or Older.
Research Committee(s)
Leukemia
Activated
08-01-2001
Closed
04-01-2003
Closed
Phase
Accrual
34%
SWOG Clinical Trial Number
S0029
Single Agent Docetaxel For Metastatic Breast Cancer In Patients Aged 70 Years And Older (And In A Cohort Of Patients Younger Than 60 Years)
Research Committee(s)
Breast Cancer
Activated
08-01-2001
Closed
06-15-2005
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0000
Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Research Committee(s)
Prevention & Epidemiology
Genitourinary Cancer
Activated
07-25-2001
Closed
06-24-2004
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0107
A Phase II Trial of Epothilone B Analogue BMS-247550 (NSC #710428) Every 21 Days in Patients With Advanced Pancreas Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
07-01-2001
Closed
06-01-2003
Closed
Phase
Accrual
81%
SWOG Clinical Trial Number
S0028
Protocol for Assessment of Gemcitabine and Paclitaxel for Metastatic Urothelial Cancer in Patients Aged 70 Years or Older (And in a Cohort of Patients Younger Than 60 Years)
Research Committee(s)
Genitourinary Cancer
Activated
07-01-2001
Closed
12-15-2006
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0111
A Phase II Trial of Epothilone B Analogue BMS-247550 (NSC #710428) (IND 59699) Administered Every 21 Days in Patients with Hormone Refractory Prostate Cancer
Research Committee(s)
Genitourinary Cancer
Activated
06-15-2001
Closed
11-15-2003
Closed
Phase
Accrual
74%
Published
SWOG Clinical Trial Number
S0023
A Phase III Trial of Cisplatin/Etoposide/Radiotherapy with Consolidation Docetacel followed by Maintenance Therapy with ZD1839 (NSC-715055) or Placebo in Patients with Inoperable Locally Advanced Stage III Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
06-15-2001
Closed
04-15-2005
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0012
A Comparative Randomized Study of Standard Doxorubicin And Cyclophosphamide Followed by Weekly Paclitaxel Vs. Weekly Doxorubicin And Daily Oral Cyclophosphamide Plus G-CSF Followed by Weekly Paclitaxel As Neoadjuvant Therapy For Inflammatory And Locally Advanced Breast Cancer
Research Committee(s)
Breast Cancer
Activated
05-01-2001
Closed
12-01-2005
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0102
Docetaxel and Vinorelbine Plus Filgrastim for HER-2 Negative, Stage IV Breast Cancer, Phase II
Research Committee(s)
Breast Cancer
Activated
05-01-2001
Closed
01-01-2004
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0109
A Phase II Study of Flavopiridol (NSC-649890) 1 Hour Bolus Days 1-3 Q 21 Days in Patients with Advanced Renal Cell Cancer
Research Committee(s)
Genitourinary Cancer
Activated
05-01-2001
Closed
02-01-2002
Closed
Phase
Accrual
87%
Published
SWOG Clinical Trial Number
S0108
Bevacizumab (rhuMAb) (NSC 704865) Therapy For Patients With Relapsed Aggressive Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
04-15-2001
Closed
12-01-2004
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0101
A Phase II Study of Gemcitabine Plus Irinotecan (CPT-11) In Patients With Esophageal Cancer.
Research Committee(s)
Gastrointestinal Cancer
Activated
04-15-2001
Closed
02-01-2003
Closed
Phase
Accrual
33%
SWOG Clinical Trial Number
S0022
Phase II Trial of Concurrent Cisplatin/Docetaxel and Radiotherapy Followed by Consolidation Docetaxel in Stage IIIB Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
03-15-2001
Closed
02-01-2003
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0009
Phase II Evaluation Of Neoadjuvant Chemotherapy, Interval Debulking Followed By Intraperitoneal Chemotherapy In Women With Stage III And IV Epithelial Ovarian Cancer, Fallopian Tube Cancer Or Primary Peritoneal Cancer
Research Committee(s)
Gynecologic Cancer
Activated
03-15-2001
Closed
02-01-2006
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0016
A Phase III Trial of CHOP vs. CHOP + Rituximab vs. CHOP + Iodine-131-Labeled Monoclonal Anti-B1 Antibody (Tositumomab) For Treatment of Newly Diagnosed Follicular Non-Hodgkin's Lymphomas
Research Committee(s)
Lymphoma
Activated
03-01-2001
Closed
10-02-2008